Nucleolar stress: Friend or foe in cardiac function?

被引:2
|
作者
Yan, Daliang [1 ]
Hua, Lu [2 ]
机构
[1] Taizhou Peoples Hosp, Dept Cardiovasc Surg, Taizhou, Peoples R China
[2] Taizhou Peoples Hosp, Dept Oncol, Taizhou, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
nucleolus; nucleolar stress; cardiac disease; nucleostemin; nucleophosmin; nucleolin; senescence; POLYMERASE-I TRANSCRIPTION; FACTOR TIF-IA; RIBOSOMAL-RNA SYNTHESIS; DNA-DAMAGE; PREMATURE SENESCENCE; HEART-FAILURE; NUCLEOSTEMIN; ACTIVATION; BIOGENESIS; PROTEIN;
D O I
10.3389/fcvm.2022.1045455
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Studies in the past decades have uncovered an emerging role of the nucleolus in stress response and human disease progression. The disruption of ribosome biogenesis in the nucleolus causes aberrant nucleolar architecture and function, termed nucleolar stress, to initiate stress-responsive pathways via nucleolar release sequestration of various proteins. While data obtained from both clinical and basic investigations have faithfully demonstrated an involvement of nucleolar stress in the pathogenesis of cardiomyopathy, much remains unclear regarding its precise role in the progression of cardiac diseases. On the one hand, the initiation of nucleolar stress following acute myocardial damage leads to the upregulation of various cardioprotective nucleolar proteins, including nucleostemin (NS), nucleophosmin (NPM) and nucleolin (NCL). As a result, nucleolar stress plays an important role in facilitating the survival and repair of cardiomyocytes. On the other hand, abnormalities in nucleolar architecture and function are correlated with the deterioration of cardiac diseases. Notably, the cardiomyocytes of advanced ischemic and dilated cardiomyopathy display impaired silver-stained nucleolar organiser regions (AgNORs) and enlarged nucleoli, resembling the characteristics of tissue aging. Collectively, nucleolar abnormalities are critically involved in the development of cardiac diseases.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Temperature control after cardiac arrest: friend or foe
    Nolan, Jerry P.
    Soar, Jasmeet
    CURRENT OPINION IN CRITICAL CARE, 2022, 28 (03) : 244 - 249
  • [32] Hyperoxia in post-cardiac arrest: friend or foe?
    Llitjos, Jean-Francois
    Cariou, Alain
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S3908 - S3910
  • [33] Effect of Ivabradine on Cardiac Ventricular Arrhythmias: Friend or Foe?
    Okninska, Marta
    Paterek, Aleksandra
    Zambrowska, Zuzanna
    Mackiewicz, Urszula
    Maczewski, Michal
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (20)
  • [34] Aprotinin use during cardiac surgery: friend or foe?
    Binks, A.
    Mouton, R.
    ANAESTHESIA, 2008, 63 (04) : 446 - 446
  • [35] MicroRNA-29a Is a Friend or Foe for Cardiac Hypertrophy?
    Tao, Hui
    Yang, Jing-Jing
    Li, Jun
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (08) : 848 - 848
  • [36] Friend or foe?
    Lawton, Graham
    NEW SCIENTIST, 2011, 212 (2841) : 46 - 49
  • [37] Friend not foe
    Ogden, Lesley Evans
    NEW SCIENTIST, 2018, 237 (3164) : 24 - 25
  • [38] Friend and foe
    Senellart, Michel
    ASTERION-PHILOSOPHIE HISTOIRE DES IDEES PENSEE POLITIQUE, 2009, (06):
  • [39] Ethanol Induced Oxidative Stress in the Vasculature: Friend or Foe
    Phillips, Shane A.
    Osborn, Kendra
    Hwang, Chueh-Lung
    Sabbahi, Ahmad
    Piano, Mariann R.
    CURRENT HYPERTENSION REVIEWS, 2021, 16 (03) : 181 - 191
  • [40] Friend or foe?
    Waste Age, 2000, 31 (06):